| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.094 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.099 | 0.7 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |